Correction: Benucci et al. Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease. J. Pers. Med. 2022, 12, 1174
- PMID: 36836609
- PMCID: PMC9965674
- DOI: 10.3390/jpm13020168
Correction: Benucci et al. Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease. J. Pers. Med. 2022, 12, 1174
Abstract
The authors wish to make the following correction to this paper [...].
Erratum for
-
Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease.J Pers Med. 2022 Jul 19;12(7):1174. doi: 10.3390/jpm12071174. J Pers Med. 2022. PMID: 35887671 Free PMC article.
References
-
- Benucci M., Damiani A., Bandinelli F., Russo E., Li Gobbi F., Grossi V., Amedei A., Infantino M., Manfredi M. Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease. J. Pers. Med. 2022;12:1174. doi: 10.3390/jpm12071174. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources